Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities
The mitochondrial isoforms VA/VB of metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1) are involved in metabolic processes, such as de novo lipogenesis and fatty acid biosynthesis. We review the drug design landscape for obtaining CA VA/VB-selective/effective inhibitors, starting from the clinical ob...
Saved in:
| Main Author: | Claudiu T. Supuran |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/14756366.2022.2121393 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elevation of hepatic de novo lipogenesis in mice with overnutrition is dependent on multiple substrates
by: Jordan W. Strober, et al.
Published: (2025-07-01) -
Synthesis, carbonic anhydrase inhibition studies and modelling investigations of phthalimide–hydantoin hybrids
by: Morteza Abdoli, et al.
Published: (2024-12-01) -
Inhibition studies of the protozoan α-carbonic anhydrase from Trypanosoma cruzi with phenols
by: Alessandro Bonardi, et al.
Published: (2022-12-01) -
Novel 3-(6-methylpyridin-2-yl)coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity
by: Haytham O. Tawfik, et al.
Published: (2022-12-01) -
An ureido-substituted benzenesulfonamide carbonic anhydrase inhibitor exerts a potent antitumor effect in vitro and in vivo
by: Giorgia Gazzaroli, et al.
Published: (2025-08-01)